MCDERMOTT ADVISES CORTERIA PHARMACEUTICALS ON EUR 65 MILLION SERIES A FINANCING ROUND
September 16, 2023
September 16, 2023
CHICAGO, Illinois, Sept. 16 -- McDermott Will and Emery, a law firm, issued the following news release:
McDermott Will & Emery has advised Corteria Pharmaceuticals, a French biotechnology company specialising in the development of therapies for certain forms of heart failure, on the completion of a EUR 65 million Series A financing round led by two new investors, French Jeito Capital and US Orbimed, with the participation of all of the previous investors (Kurma Partners, Fountai . . .
McDermott Will & Emery has advised Corteria Pharmaceuticals, a French biotechnology company specialising in the development of therapies for certain forms of heart failure, on the completion of a EUR 65 million Series A financing round led by two new investors, French Jeito Capital and US Orbimed, with the participation of all of the previous investors (Kurma Partners, Fountai . . .